Translational Cancer Research in ASTRO 2013 meeting, Atlanta

Although swamped in the vast Exhibit Hall, the sign of Translational Cancer Research (TCR) was eye-catching and attracted a large number of attendees to sign up for Newsletters and to pick up sample copies or flyers during the American Society for Radiation Oncology’s 55th Annual Meeting (ASTRO 2013) held in Atlanta, September 22 to 25, 2013 (Figure 1). The editorial team of TCR attended this meeting in order to better keep up with the lasted progress in radiation oncology, at the same time, to introduce this potential journal to more radiation oncologists.

Figure 1 Attendees were getting to know about the journal and signing up for Newsletters.

Featuring novel biological principles and targeted radiosensitization strategies, “DNA Damage and Repair” was the very first and hot Scientific Session in this ASTRO, in the meantime in the Exhibit Hall, the editorial team of TCR exhibited a special issue published in June Issue of 2013 on “DNA Damage and Repair” guest edited by Drs. David Chen and Benjamin Chen from University of Texas Southwestern Medical Center (Figure 2, http://www.thetcr.org/issue/view/63). The issue received warm welcome by physicians attended. It is hoped that this “DNA Damage and Repair” edition will serve as a valuable resource for the biologist community to stimulate more in-depth studies.

Figure 2 TCR Special issues on “DNA Damage and Repair”, “Nanotechnology in Radiation Research” and “Particle Beam Therapy”.

Special issues on “Particle Beam Therapy I&II” and “Nanotechnology in Radiation Research” were also being well introduced (Figures 2,3) in this meeting. The editorial team also prepared little lovely gifts for attendees visiting our exhibition booth (Figure 4). Many editorial board members as well as authors stopped by to support the exhibition (Figure 5).

Figure 3 ASTRO attendees were picking up free sample copies of TCR and signing up for the Newsletters.

Figure 4 Attendees adored the little gifts.

Figure 5 Editorial team of TCR in the exhibition hall of ASTRO. From left to right: Elva S. Zheng, science editor, Prof. Eric Y. Chuang, Editor-in-Chief, Dr. Reinhard W. Schulte, editorial board member, and Nancy Q. Zhong, science editor.

With the journal’s overall goal to improve the clinical care for cancer patients, the editorial team is dedicated to keeping pace and publishing results of novel research investigations which bridge the laboratory and clinical settings in cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers. The upcoming special issues of TCR include “Intraoperative Radiotherapy”, “Statistical applications in biomedical genomics”, “Stereotactic Body Radiation Therapy” and “Radiation Effects in the CNS” in 2014.

Acknowledgments

Funding: None.

Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Translational Cancer Research. The article did not undergo external peer review.

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.3978/j.issn.2218-676X.2013.12.02). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.